181208-36-6

Basic information

• Product Name: 6,7-Epoxy Docetaxel (Mixture of Diastereomers)
• Synonyms: 6,7-Epoxy Docetaxel (Mixture of Diastereomers);3a-(Acetyloxy)-4-(benzoyloxy)-1a,1b,3a,3b,4,5,6,7,10,11,11a,11b-dodecahydro-5,10-dihydroxy-8,11a,12,12-tetraMethyl-11-oxo-5,9-Methano-3H-cyclodec[3,4]oxireno[5,6]benz[1,2-b]oxet-7-yl Ester;β-[[(1,1-DiMethylethoxy)carbonyl]aMino]-α-hydroxybenzenepropanoic Acid
• CAS NO: 181208-36-6
• Molecular Formula: C43H51NO14
• Molecular Weight: 805.86334
• Product Categories: Aromatics;Chiral Reagents;Intermediates;Intermediates & Fine Chemicals;Pharmaceuticals;Aromatics, Chiral Reagents, Intermediates, Pharmaceuticals, Intermediates & Fine Chemicals
• Mol File: 181208-36-6.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 6,7-Epoxy Docetaxel (Mixture of Diastereomers)(CAS DataBase Reference)
• NIST Chemistry Reference: 6,7-Epoxy Docetaxel (Mixture of Diastereomers)(181208-36-6)
• EPA Substance Registry System: 6,7-Epoxy Docetaxel (Mixture of Diastereomers)(181208-36-6)

Safety Data

• Hazardous Substances Data: 181208-36-6(Hazardous Substances Data)

Usage

Description

6,7-Epoxy Docetaxel (Mixture of Diastereomers) is a taxane derivative that has been modified at the 6 and 7 positions. This modification enhances its potential as an antitumor agent, making it a promising candidate for cancer treatment.

Uses

Used in Pharmaceutical Industry:
6,7-Epoxy Docetaxel (Mixture of Diastereomers) is used as an antitumor agent for its potential to treat various types of cancer. The modification at the 6 and 7 positions allows for improved interaction with cancer cells, leading to increased efficacy in cancer treatment.
Used in Cancer Research:
6,7-Epoxy Docetaxel (Mixture of Diastereomers) is utilized in cancer research as a valuable tool for studying the mechanisms of action and potential synergistic effects with other chemotherapeutic drugs. This research can contribute to the development of more effective cancer treatment strategies and improve patient outcomes.
Used in Drug Development:
6,7-Epoxy Docetaxel (Mixture of Diastereomers) serves as a key component in the development of novel cancer drugs. Its unique properties and potential as an antitumor agent make it an attractive candidate for further investigation and optimization, with the goal of creating more effective and targeted cancer therapies.